The role of atrial sensing for new‐onset atrial arrhythmias diagnosis and management in single‐chamber implantable cardioverter‐defibrillator recipients: Results from the THINGS registry

Atrial tachycardia/fibrillation (AT/AF) episodes are common in implantable cardioverter‐defibrillator (ICD) recipients and can be undetected by standard single‐chamber devices. This study aims to explore whether a single‐lead ICD with an atrial dipole (ICD DX; BIOTRONIK SE & Co, Berlin, Germany) could improve the AT/AF diagnosis and management as compared to standard ICD (ICD VR).

[1]  A. Capucci,et al.  Are Atrial High-Rate Episodes Associated With Increased Risk of Ventricular Arrhythmias and Mortality? , 2019, JACC. Clinical electrophysiology.

[2]  Daniel Y. Choi,et al.  Subclinical atrial fibrillation detection with a floating atrial sensing dipole in single lead implantable cardioverter‐defibrillator systems: Results of the SENSE trial , 2019, Journal of cardiovascular electrophysiology.

[3]  Mintu P Turakhia,et al.  Practice Variation in Anticoagulation Prescription and Outcomes After Device-Detected Atrial Fibrillation. , 2019, Circulation.

[4]  A. Auricchio,et al.  Estimating the incidence of atrial fibrillation in single‐chamber implantable cardioverter defibrillator patients , 2018, Pacing and clinical electrophysiology : PACE.

[5]  T. Reinhold,et al.  Cost Saving Potential of an Early Detection of Atrial Fibrillation in Patients after ICD Implantation , 2018, BioMed research international.

[6]  A. Capucci,et al.  Does the CHA2DS2-VASc score reliably predict atrial arrhythmias? Analysis of a nationwide database of remote monitoring data transmitted daily from cardiac implantable electronic devices. , 2018, Heart rhythm.

[7]  Rajiv Mahajan,et al.  Subclinical device-detected atrial fibrillation and stroke risk: a systematic review and meta-analysis , 2018, European heart journal.

[8]  L. Jordaens,et al.  Catheter Ablation for Atrial Fibrillation with Heart Failure , 2018, The New England journal of medicine.

[9]  C. Valzania,et al.  Less is more: Can we achieve cardiac resynchronization with 2 leads only? , 2017, International journal of cardiology.

[10]  L. Fauchier,et al.  Dual- vs. single-chamber defibrillators for primary prevention of sudden cardiac death: long-term follow-up of the Défibrillateur Automatique Implantable—Prévention Primaire registry , 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[11]  Panos Vardas,et al.  Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non–vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH–AFNET 6) trial , 2017, American heart journal.

[12]  J. Healey,et al.  The Dx-AF study: a prospective, multicenter, randomized controlled trial comparing VDD-ICD to VVI-ICD in detecting sub-clinical atrial fibrillation in defibrillator patients , 2017, Journal of Interventional Cardiac Electrophysiology.

[13]  Philippe Mabo,et al.  Rationale and design of the Apixaban for the Reduction of Thrombo‐Embolism in Patients With Device‐Detected Sub‐Clinical Atrial Fibrillation (ARTESiA) trial , 2017, American heart journal.

[14]  A. Curnis,et al.  Predicting the difficulty of a transvenous lead extraction procedure: Validation of the LED index , 2017, Journal of cardiovascular electrophysiology.

[15]  A. Capucci,et al.  Can we predict new AF occurrence in single-chamber ICD patients? Insights from an observational investigation. , 2017, International journal of cardiology.

[16]  Ulrich Schotten,et al.  2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS. , 2017, Revista espanola de cardiologia.

[17]  Musab Alqasrawi,et al.  Long‐Term Stability and Clinical Utility of Amplified Atrial Electrograms in a Single‐Lead ICD System with Floating Atrial Electrodes , 2016, Pacing and clinical electrophysiology : PACE.

[18]  P. Kirchhof,et al.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[19]  P. Friedman,et al.  Performance of Atrial Fibrillation Detection in a New Single‐Chamber ICD , 2016, Pacing and clinical electrophysiology : PACE.

[20]  D. V. van Veldhuisen,et al.  2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. , 2016, Revista espanola de cardiologia.

[21]  F. Quartieri,et al.  Implantable Cardioverter Defibrillator System with Floating Atrial Sensing Dipole: A Single‐Center Experience , 2014, Pacing and clinical electrophysiology : PACE.

[22]  C. Murray,et al.  Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study , 2014, Circulation.

[23]  Ellen Aagaard Nohr,et al.  Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark , 2013, European heart journal.

[24]  A. Banerjee,et al.  Pattern of atrial fibrillation and risk of outcomes: the Loire Valley Atrial Fibrillation Project. , 2013, International journal of cardiology.

[25]  Gregory Y H Lip,et al.  Prevalence of atrial fibrillation in the general population and in high-risk groups: the ECHOES study. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[26]  A. Capucci,et al.  Subclinical atrial fibrillation and the risk of stroke. , 2012, The New England journal of medicine.

[27]  L. Eckardt,et al.  Comparison of a Novel, Single-Lead Atrial Sensing System With a Dual-Chamber Implantable Cardioverter-Defibrillator System in Patients Without Antibradycardia Pacing Indications: Results of a Randomized Study , 2011, Circulation. Arrhythmia and electrophysiology.

[28]  Dongfeng Qi,et al.  The Relationship Between Daily Atrial Tachyarrhythmia Burden From Implantable Device Diagnostics and Stroke Risk: The TRENDS Study , 2009, Circulation. Arrhythmia and electrophysiology.

[29]  A. Capucci,et al.  Presence and Duration of Atrial Fibrillation Detected by Continuous Monitoring: Crucial Implications for the Risk of Thromboembolic Events , 2009, Journal of cardiovascular electrophysiology.

[30]  Jacques Victor,et al.  Risk Factors Related to Infections of Implanted Pacemakers and Cardioverter-Defibrillators: Results of a Large Prospective Study , 2007, Circulation.

[31]  S. Lévy,et al.  Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation. , 2007, American heart journal.

[32]  A. Capucci,et al.  Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relation with arrhythmia termination , 1999, Heart.

[33]  G. Nollo,et al.  Dynamic electrophysiological behavior of human atria during paroxysmal atrial fibrillation. , 1995, Circulation.

[34]  N. Kouchoukos,et al.  Characterization of Atrial Fibrillation in Man: Studies Following Open Heart Surgery * , 1978, Pacing and clinical electrophysiology : PACE.

[35]  Andrea Mazzanti,et al.  [2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death]. , 2015, Kardiologia polska.